32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This book depicts about Pharmaceutical nanotechnology which has given all the more tweaked conclusion and centered treatment of diseases at a sub-atomic level. Pharmaceutical nanotechnology presents progressive chances to battle against numerous sickness complications. This field also gives chances to enhance materials, restorative gadgets and help to grow new innovations where existing and more traditional advances might be achieving their cutoff points. Nanopharmaceuticals which are colloidal particles of 10 to 1,000 nanometers (1 micron) in estimate have capability to distinguish disease…mehr

Produktbeschreibung
This book depicts about Pharmaceutical nanotechnology which has given all the more tweaked conclusion and centered treatment of diseases at a sub-atomic level. Pharmaceutical nanotechnology presents progressive chances to battle against numerous sickness complications. This field also gives chances to enhance materials, restorative gadgets and help to grow new innovations where existing and more traditional advances might be achieving their cutoff points. Nanopharmaceuticals which are colloidal particles of 10 to 1,000 nanometers (1 micron) in estimate have capability to distinguish disease and have colossal potential in tending to the disappointment of customary therapeutics and offer site particular focus of dynamic agents. Nanotechnology has made a capable effect in different fields of medicine including cardiology, ophthalmology, endocrinology, oncology, pulmonology, immunology and so on., and to profoundly specific territories like delivery of genes, brain targeting , tumor focusing and oral immunization.
Autorenporträt
Mr. Shahid Nazir Wani B. Pharm from SCP, Rajasthan, India had completed his bachelors thesis on Nanopharmaceuticals: A New Perspective of drug delivery system under Dr. Janmajoy Banerjee & is pursuing M. Pharm in Pharmacology from Arya College of Pharmacy, Jaipur. He had published some articles and is working on an article of receptor pharmacology.